Pancreatic Cancer Research

ResearcherChongqing Medical UniversityActive in the last 2 years

Wenzhi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9692-4747; OpenAlex author ID A5101562846. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. [Low-intensity pulsed ultrasound and oridonin synergistically induce ferroptosis of pancreatic cancer cells by activating PIEZO1 via the Nrf2/HO-1/GPX4 pathway… Co-author DOI 10.12122/j.issn.1673-4254.2025.10.12↗
  2. The dose of focused ultrasound ablation surgery (FUAS) for unresectable pancreatic cancer is predictable: A multicenter retrospective study. Last author DOI 10.1097/md.0000000000034684↗
  3. Systematic review and trial sequential analysis of high-intensity focused ultrasound combined with chemotherapy versus chemotherapy in the treatment of unresec… Last author DOI 10.1080/02656736.2021.1962550↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Guo · 2 shared papers, 2021–2023 · strength 0.37
  2. Nianzhi Chen · 1 shared paper, 2025 · strength 0.30
  3. Bihang Sun · 1 shared paper, 2025 · strength 0.30
  4. Chao Yang · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.